Shan Mou
- Infectious Diseases top 10%
- Biomedical Engineering
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Materials Chemistry
- Topics
- SARS-CoV-2 and COVID-19 Research (3 papers)MRI in cancer diagnosis (3 papers)COVID-19 Clinical Research Studies (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Shan Mou
14 papers receiving 334 citations
Peers
Comparison fields: 5 of 86
- Infectious Diseases 121
- Biomedical Engineering 116
- Molecular Biology 90
- Pulmonary and Respiratory Medicine 39
- Materials Chemistry 33
Countries citing papers authored by Shan Mou
This map shows the geographic impact of Shan Mou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Mou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Mou more than expected).
Fields of papers citing papers by Shan Mou
This network shows the impact of papers produced by Shan Mou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Mou. The network helps show where Shan Mou may publish in the future.
Co-authorship network of co-authors of Shan Mou
This figure shows the co-authorship network connecting the top 25 collaborators of Shan Mou. A scholar is included among the top collaborators of Shan Mou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan Mou. Shan Mou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 12 | |
| 3 | 3 | |
| 4 | 6 | |
| 5 | 2 | |
| 6 | 0 | |
| 7 | 8 | |
| 8 | 2 | |
| 9 | 4 | |
| 10 | 1 | |
| 11 | 11 | |
| 12 | 259 | |
| 13 | 7 | |
| 14 | 2 | |
| 15 | 21 | |
| 16 | [Analysis of associated factors for remission and relapse in proliferative and membranous lupus nephritis patients: a 4-year follow-up study]. | 0 |
| 17 | 1 |
About Shan Mou
Shan Mou is a scholar working on Nephrology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases, having authored 17 papers that have together received 339 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), MRI in cancer diagnosis (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Infectious Diseases (121 citations), Nephrology (30 citations) and General Dentistry (7 citations). Shan Mou has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Wei Tao, Zhongmin Tang, Kam W. Leong, Na Kong, Weihong Tan, Ping Hu, Jianlin Shi, Róbert Langer, Yihai Cao and Jong Seung Kim. Their work appears in journals such as Nature Reviews Materials, Frontiers in Pharmacology and Journal of Magnetic Resonance Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.